// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Drug Survival of Biologics in Rheumatoid Arthritis Patients in a Canadian Patient Cohort

Marie-Jeanne Rioux - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

Robert Landewe - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Certolizumab pegol

The Rituximab Registry at the Centre de Rhumatologie de -Est du Quebec: Description of the Real World, Canadian Rural Patient Cohort

Marie-Jeanne Rioux - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Rituximab

Quality Assurance Audit of the use of Liver Function Tests to Adjust Methotrexate Dosing in Rheumatology Patients

Nina Lathia - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alkaline phosphatase

Are there Gender Specific Differences in Patient Reported Outcomes at Initiation of Golimumab Treatment in Rheumatoid Arthritis?

William Bensen - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

golimumab

Methotrexate Use at Infliximab Initiation and Impact on Treatment Outcomes: An Analysis from the Canadian Registry, BioTRAC

Carter Thorne - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methotrexate

A Case of Multiple Myeloma Presenting as Polyarthritis and Cutaneous Vasculitis

Raman Rai - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does Specific Joint Involvement in Rheumatoid Arthritis Patients Predict Patient Reported Outcomes? Implications for Clinical Practice

William Bensen - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Infliximab

Construct Validity and Test-Retest Reliability of the OA GO AWAY, a Self-Management Intervention for Patients with OA of the Hip or Knee to Promote Exercise Adherence

Karine Toupin-April - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Schnitzlers Syndrome Treated with Anakinra: Report of Effect on Two Refractory Cases

Aurore Fifi-Mah - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Anakinra

Differential Relative Contribution of Individual Components on DAS28 Over Time. An Analysis from the Prospective, Observational Registry, BioTRAC

Dalton Sholter - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Infliximab

Coexistence of Rheumatoid Arthritis and Gout: Clinical Characteristics and Trend (2004-2013)

Alex Yan - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Work Limitations and Disability in a Canadian Population with Systemic Vasculitis

Sherry Rohekar - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ovarian Involvement in Eosinophilic Granulomatosis with Polyangiitis Maia

Regina Taylor-Gjevre - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Greater Trochanteric Enthesitis with Sacroiliitis and Hip Arthritis Presenting as Gait Abnormalities in Young Children: Report of 3 Cases

Jessica Breton - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

N/A

Source and Quality of the Evidence used in the Development of the 2012 American College of Rheumatology (ACR) Knee and Hip Osteoarthritis Clinical Practice Guidelines

Karine Toupin-April - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Unilateral Small Vessel Vasculitis of the Leg Possible Complication of Intra-Articular Steroid Injection?

Iman Hemmati - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Leukocytoclastic vasculitis

N/A

Effect of Biologic Disease Modifiers (BDMARDs) on Cardiovascular Risk of Patients with Rheumatoid Arthritis (RA)-2 Years Prospective Cohort Study

Rana Aslanov - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Consumer Informing Research: A Survey of Canadian- Views and Research Priorities in Chronic Inflammatory Diseases

Gail Attara - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

A Paradigm Change for Treatment Strategies for Fibromyalgia Syndrome Reflected by Recommendations of Recent Evidence-Based Interdisciplinary Guidelines Developed Independently in Three

Dan Buskila - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibromyalgia

N/A

Copyright © 2026. QuantiNova All rights reserved